Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Neuroscience and Biobehavioral Reviews
K R SabithaDinesh Upadhya


The pathological alterations that manifest during the early embryonic development due to inherited and acquired factors trigger various neurodevelopmental disorders (NDDs). Besides major NDDs, there are several rare NDDs, exhibiting specific characteristics and varying levels of severity triggered due to genetic and epigenetic anomalies. The rarity of subjects, paucity of neural tissues for detailed analysis, and the unavailability of disease-specific animal models have hampered detailed comprehension of rare NDDs, imposing heightened challenge to the medical and scientific community until a decade ago. The generation of functional neurons and glia through directed differentiation protocols for patient-derived iPSCs, CRISPR/Cas9 technology, and 3D brain organoid models have provided an excellent opportunity and vibrant resource for decoding the etiology of brain development for rare NDDs caused due to monogenic as well as polygenic disorders. The present review identifies cellular and molecular phenotypes demonstrated from patient-derived iPSCs and possible therapeutic opportunities identified for these disorders. New insights to reinforce the existing knowledge of the pathophysiology of these disorders and prospective therapeu...Continue Reading


Jun 1, 1989·The American Journal of Anatomy·A B Johnson, A Bettica
Oct 17, 1996·The New England Journal of Medicine·A DürrM Koenig
Jul 12, 1996·American Journal of Medical Genetics·G TurnerH Robinson
Apr 1, 1996·Neurobiology of Disease·T O Crawford, C A Pardo
Jun 12, 1999·American Journal of Human Genetics·Y JiangA L Beaudet
May 5, 2000·Journal of Neurology·S JablonkaM Sendtner
Apr 10, 2002·Neurology·T SugawaraK Yamakawa
May 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·A Lavandeira
Sep 18, 2003·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Sibylle Jablonka, Michael Sendtner
Jan 26, 2005·Brain & Development·Charles A Williams
May 10, 2005·Human Mutation·John C MulleyLouise A Harkin
Aug 3, 2005·The Journal of Clinical Investigation·Miriam H Meisler, Jennifer A Kearney
Nov 8, 2005·Science·Mriganka Sur, John L R Rubenstein
Feb 4, 2006·Acta Neuropathologica·Volney L SheenChristopher A Walsh
Apr 28, 2006·Annals of Neurology·Volney L SheenChristopher A Walsh
Jun 16, 2006·Journal of Intellectual Disability Research : JIDR·P LewisS Schroeder
Aug 22, 2006·Nature Chemical Biology·David HermanJoel M Gottesfeld
Jan 24, 2007·Lancet·Francis O Walker
Jun 1, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ikuo OgiwaraKazuhiro Yamakawa
Jun 29, 2007·Human Molecular Genetics·Alain MartelliHélène Puccio
Nov 9, 2007·Neuron·Maria Chahrour, Huda Y Zoghbi
May 29, 2008·Orphanet Journal of Rare Diseases·Mary C Phelan
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Sep 8, 2009·Nature Medicine·Salvatore Albani, Berent Prakken

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Brain Organoids in Disease Modeling

Brain organoids are three-dimensional cell culture models derived from human pluripotent stem cells. Since they resemble the embryonic brain, they can be used to help study brain biology, early brain development, and brain diseases. Discover the latest research on brain organoids in disease modeling here.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.